Showing results (1991-2000 of 2,271) with videos related to
Sort By:
Pageof 228
The Journal of Clinical Investigation|March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.The Lancet. Respiratory Medicine|September 22, 2025
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised studyShun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, et al.Nature Immunology|July 28, 2026
Human lungs maintain tissue-resident memory T cells against a broad spectrum of pathogensVicente Fajardo-Rosas, Aquib Ehtram, Isabel Marchand-Casas, et al.Frontiers in Immunology|December 24, 2024
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adultsKohei Kometani, Takaaki Yorimitsu, Norihide Jo, et al.Nutrition (Burbank, Los Angeles County, Calif.)|March 9, 2018
Do dietary patterns determine levels of vitamin B6, folate, and vitamin B12 intake and corresponding biomarkers in European adolescents? The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) studyIris Iglesia, Inge Huybrechts, Theodora Mouratidou, et al.Pathogens & Immunity|September 20, 2021
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA LevelShay Leary, Silvana Gaudieri, Matthew D Parker, et al.Science (New York, N.Y.)|January 7, 2021
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionJennifer M Dan, Jose Mateus, Yu Kato, et al.Iscience|January 22, 2026
The GF-NEO discovery platform unveils a [KQE][DG] sequence motif within fusion neoantigens in pediatric cancerChristopher Savoie, Zhaoguan Wu, Frederic Saab, et al.Cell Host & Microbe|January 11, 2024
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variantRofhiwa Nesamari, Millicent A Omondi, Richard Baguma, et al.Journal of Autoimmunity|February 20, 2019
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritisIlenia Cammarata, Carmela Martire, Alessandra Citro, et al.Pageof 228